BioLife Solutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
BioLife Solutions, Inc. (BLFS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 2.12% for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2018-03-09
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-09-30 was 0.00%, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-06-30 was 0.00%, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2017-03-31 was 2.07%, a 25.45% increase year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2016-09-30 was 1.33%, a 24.86% decline year-over-year.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2017 was 2.12%, a 40.40% increase from fiscal 2016.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2016 was 1.51%, a 14.69% decline from fiscal 2015.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2015 was 1.77%, a 11.94% decline from fiscal 2014.
- BioLife Solutions, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2014 was 2.01%, a 10.67% decline from fiscal 2013.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2017-12-31 | 2.12% 10-K · filed 2018-03-09 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2017-11-09 | 2.07% 10-Q · filed 2017-11-09 | ||
| 2017-06-30 | 0.00% 10-Q · filed 2017-08-11 | 2.07% 10-Q · filed 2017-08-11 | ||
| 2017-03-31 | 2.07% 10-Q · filed 2017-05-12 | |||
| 2016-12-31 | 1.51% 10-K · filed 2018-03-09 | |||
| 2016-09-30 | 1.33% 10-Q · filed 2017-11-09 | 1.51% 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | 1.45% 10-Q · filed 2017-08-11 | 1.52% 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | 1.65% 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | 1.77% 10-K · filed 2017-03-15 | |||
| 2015-09-30 | 1.77% 10-Q · filed 2016-11-10 | 1.77% 10-Q · filed 2016-11-10 | ||
| 2015-06-30 | 1.77% 10-Q · filed 2016-08-11 | 1.77% 10-Q · filed 2016-08-11 | ||
| 2014-12-31 | 2.01% 10-K · filed 2016-02-25 | |||
| 2014-09-30 | 1.93% 10-Q · filed 2015-11-16 | 2.02% 10-Q · filed 2015-11-16 | ||
| 2014-06-30 | 2.14% 10-Q · filed 2015-08-06 | 2.14% 10-Q · filed 2015-08-06 | ||
| 2013-12-31 | 2.25% 10-K · filed 2015-03-12 | |||
| 2013-09-30 | 2.25% 10-Q · filed 2014-11-06 | 2.25% 10-Q · filed 2014-11-06 | ||
| 2013-06-30 | 0.00% 10-Q · filed 2014-08-07 | 0.00% 10-Q · filed 2014-08-07 | ||
| 2012-12-31 | 0.77% 10-K · filed 2014-02-12 | |||
| 2012-09-30 | 0.71% 10-Q · filed 2013-11-14 | 0.78% 10-Q · filed 2013-11-14 | ||
| 2012-06-30 | 0.76% 10-Q · filed 2013-08-12 | 0.80% 10-Q · filed 2013-08-12 | ||
| 2012-03-31 | 0.83% 10-Q · filed 2013-05-14 | |||
| 2011-09-30 | 1.02% 10-Q · filed 2012-11-13 | 2.15% 10-Q · filed 2012-11-13 | ||
| 2011-06-30 | 0.00% 10-Q · filed 2012-08-14 | 2.25% 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |